Furthermore, impact of protein kinase inhibitors: LY294002, U126, everolimus, and combination of siRNA for N-cadherin and protein kinase inhibitors on the process of melanoma cell invasion reported here suggests involvement of all three kinases in N-cadherin-initiated signalling. The gene discussed is CDH2; the disease is melanoma.